Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease
Condition: Fatty Liver, Nonalcoholic Interventions: Drug: Cilostazol 50 MG; Drug: Placebo Sponsor: Sadat City University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2021 Category: Research Source Type: clinical trials
Retina is a Marker for Cerebrovascular Heath
Conditions: Cerebral Small Vessel Diseases; Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy; Cerebral Microbleeding; Sporadic White Matter Disease Intervention: Drug: Cilostazol Sponsor: Mayo Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2021 Category: Research Source Type: clinical trials